Background: This retrospective study investigates the efficacy and safety of the novel Celt ACD vascular closure device (VCD) following antegrade and retrograde common femoral artery (CFA) punctures for the treatment of peripheral artery disease in a challenging patient collective (e.g. calcifications, obesity, and anticoagulation).
View Article and Find Full Text PDF